Current And Emerging Tools For Assessing Diabetic Peripheral Neuropathy

Author(s): 
Maria K. Piemontese, DPM, and Andrew J. Meyr, DPM

References:

1. Reiber G, Vileikyte L, Moyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999 Jan; 22(1):157-162.
2. Young MJ, Boulton AJ, MacLeod AF, et al. A multicentre study of the prevalence of diabetic neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993 Feb; 36(2):150-4.
3. Furnary AP, Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Semin Thorax Cardiovasc Surg. 2006 Winter; 18(4):302-8.
4. Ganesh SP, Pietrobon R, Cecilio WA, et al. The impact of diabetes on patient outcomes after ankle fracture. J Bone Joint Surg Am. 2005 Aug; 87(8):1712-8.
5. Brown JA, Cook C, Pietrobon R, et al. Diabetes and early postoperative outcomes following lumbar fusion. Spine. 2007 Sep; 32(20):2214-9.
6. Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am. 2008 Jan; 90(1):62-9.
7. Kline AJ, Gruen GS, Pape HC, et al. Early complications following the operative treatment of pilon fractures with and without diabetes. Foot Ankle Int. 2009 Nov; 30(11):1042-7.
8. Wukich DK, Lowery NJ, McMillen RL, et al. Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus. J Bone Joint Surg Am. 2010 Feb; 92(2):287-95.
9. Backonja MM. Painful neuropathies. In: Loeser JD (ed.) Bonica’s management of pain. Lippincott Williams & Wilkins, Philadelphia, 2001, pp. 371-379.
10. Cornell RS, Ducic I. Painful diabetic neuropathy. Clin Podiatr Med Surg. 2008 Jul; 25(3):347-60.
11. Tkac I, Bril V. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care. 1998 Oct; 21(10):1749-52.
12. Dickinson PJ, Carrington AL, Frost GS, et al. Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev. 2002 Jul-Aug; 18(4):260-72.
13. Meier MR, Desrosiers J, Bourassa P, et al. Effect of type II diabetic peripheral neuropathy on gait termination in the elderly. Diabetologia. 2001 May; 44(5):585-92.
14. Richardson JK. Factors associated with falls in older patients with diffuse polyneuropathy. J Am Geriatr Soc. 2002 Nov; 50(11):1167-73.
15. Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000 Apr; 17(4):253-8.
16. Bornholt SF, Mikkelsen JD, Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animals models of acute, persistent and neuropathic pain. Neuropharmacology. 2005 Feb; 48(2):252-63.
17. Gibbons CH, Illigens BM, Wang N, et al. Quantification of sweat gland innervations: a clinical-pathologic correlation. Neurology. 2009 Apr 28; 72(17):1479-86.
18. Edmonds ME, Nicolaides KH, Watkins PJ. Autonomic neuropathy and diabetic foot ulceration. Diabet Med. 1986 Jan; 3(1):56-9.
19. Rith-Najarian S, Branchaud C, Beaulieu O, et al. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998 Aug; 47(2):127-32.
20. Lee S, Kim H, Choi S, Park Y, et al. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci. 2003 Feb; 18(1):103-7.
21. McGill M, Molyneaux L, Spencer R, et al. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care. 1999 Apr; 22(4): 598-602.
22. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care. 1995 Feb; 18(2):216-9.
23. Feldman EL, Stevens MJ. Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci. 1994 Nov; 21(4):S3-7.
24. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994 Nov; 17(11):1281-9.

Add new comment